An NIH-funded research resource center, associated with the UW Medicine Memory and Brain Wellness Center
December 04, 2023
The drug has been shown to reduce cognitive decline in patients with early Alzheimer's.
Read More
Categories: Science Updates, New FDA Drug Approvals